Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel HDAC inhibitors in early development at Roche

Aug. 23, 2002

STO-609, a potent and selective CaM-KK inhibitor synthesized at Sumitomo

Aug. 23, 2002

ZYC-101a shows potential in the treatment of anal dysplasia

Aug. 22, 2002

R-115777 radiosensitizes previously radioresistant human glioma cells

Aug. 22, 2002

In vitro and in vivo characterization of new KDR inhibitors disclosed by Merck

Aug. 21, 2002

Merck reports novel KDR inhibitors at ACS meeting

Aug. 21, 2002

Results on FTase inhibitor SCH-400 presented at ACS

Aug. 21, 2002

OSI and Genentech update progress of Tarceva development program

Aug. 21, 2002

Antioxidant epicatechin derivatives for use in cancer, cardiovascular disorders, etc.

Aug. 21, 2002

Abbott reports novel HDAC inhibitors at the ACS meeting

Aug. 20, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...